BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

699 related articles for article (PubMed ID: 33172223)

  • 1. Severe, Symptomatic Reinfection in a Patient with COVID-19.
    Selvaraj V; Herman K; Dapaah-Afriyie K
    R I Med J (2013); 2020 Nov; 103(10):24-26. PubMed ID: 33172223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covid-19 antibody tests: a briefing.
    Baraniuk C
    BMJ; 2020 Jun; 369():m2284. PubMed ID: 32580937
    [No Abstract]   [Full Text] [Related]  

  • 3. A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 Antibodies.
    Goetz L; Yang J; Greene W; Zhu Y
    J Appl Lab Med; 2020 Nov; 5(6):1401-1405. PubMed ID: 32745181
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic.
    Stavert R; Meydani-Korb A; de Leon D; Osgood R; Blau J; Luu T
    J Am Acad Dermatol; 2020 Dec; 83(6):1753-1755. PubMed ID: 32822790
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapid roll out of SARS-CoV-2 antibody testing-a concern.
    Andersson M; Low N; French N; Greenhalgh T; Jeffery K; Brent A; Ball J; Pollock A; McCoy D; Iturriza-Gomara M; Buchan I; Salisbury H; Pillay D; Irving W
    BMJ; 2020 Jun; 369():m2420. PubMed ID: 32580928
    [No Abstract]   [Full Text] [Related]  

  • 6. Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series.
    Vetter P; Eberhardt CS; Meyer B; Martinez Murillo PA; Torriani G; Pigny F; Lemeille S; Cordey S; Laubscher F; Vu DL; Calame A; Schibler M; Jacquerioz F; Blanchard-Rohner G; Siegrist CA; Kaiser L; Didierlaurent AM; Eckerle I
    mSphere; 2020 Nov; 5(6):. PubMed ID: 33177214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 serologic testing: FAQs and caveats.
    Kadkhoda K
    Cleve Clin J Med; 2020 Jun; 87(6):329-333. PubMed ID: 32434807
    [No Abstract]   [Full Text] [Related]  

  • 8. Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS-CoV-2/COVID-19.
    Patel R; Babady E; Theel ES; Storch GA; Pinsky BA; St George K; Smith TC; Bertuzzi S
    mBio; 2020 Mar; 11(2):. PubMed ID: 32217609
    [No Abstract]   [Full Text] [Related]  

  • 9. Will antibody tests for the coronavirus really change everything?
    Mallapaty S
    Nature; 2020 Apr; 580(7805):571-572. PubMed ID: 32313159
    [No Abstract]   [Full Text] [Related]  

  • 10. Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients.
    Yu HQ; Sun BQ; Fang ZF; Zhao JC; Liu XY; Li YM; Sun XZ; Liang HF; Zhong B; Huang ZF; Zheng PY; Tian LF; Qu HQ; Liu DC; Wang EY; Xiao XJ; Li SY; Ye F; Guan L; Hu DS; Hakonarson H; Liu ZG; Zhong NS
    Eur Respir J; 2020 Aug; 56(2):. PubMed ID: 32398307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-Comparison of a Chemiluminescent Platform and a Commercial Receptor Binding Domain-Based ELISA for Detecting SARS-CoV-2 IgG.
    Antoine-Reid T; Malone J; Maris AS; White-Abell J; Schmitz JE
    J Appl Lab Med; 2020 Nov; 5(6):1416-1420. PubMed ID: 32750140
    [No Abstract]   [Full Text] [Related]  

  • 12. The COVID-19 Pandemic in the US: A Clinical Update.
    Omer SB; Malani P; Del Rio C
    JAMA; 2020 May; 323(18):1767-1768. PubMed ID: 32250388
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapid roll out of SARS-CoV-2 antibody testing: even at high levels of specificity, an important proportion of test results will be false positives.
    Gruer L; Bhopal R
    BMJ; 2020 Jul; 370():m2910. PubMed ID: 32699002
    [No Abstract]   [Full Text] [Related]  

  • 14. Is reinfection possible after recovery from COVID-19?
    Law SK; Leung AWN; Xu C
    Hong Kong Med J; 2020 Jun; 26(3):264-265. PubMed ID: 32536614
    [No Abstract]   [Full Text] [Related]  

  • 15. How deadly is the coronavirus? Scientists are close to an answer.
    Mallapaty S
    Nature; 2020 Jun; 582(7813):467-468. PubMed ID: 32546810
    [No Abstract]   [Full Text] [Related]  

  • 16. The Detection of Novel Coronavirus Antibodies is an Important Supplementary Detection Method for Screening of High-Risk Population.
    Wang D; Jia X; Huang T; Wang H; Li S; Ren T; Nie H; Chen Z; Song C; Zhou Y; Ma W; Shen H
    Clin Lab; 2020 Jul; 66(7):. PubMed ID: 32658430
    [No Abstract]   [Full Text] [Related]  

  • 17. Coronavirus Disease 2019 Test Results After Clinical Recovery and Hospital Discharge Among Patients in China.
    Wu J; Liu X; Liu J; Liao H; Long S; Zhou N; Wu P
    JAMA Netw Open; 2020 May; 3(5):e209759. PubMed ID: 32442288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The explosion of new coronavirus tests that could help to end the pandemic.
    Guglielmi G
    Nature; 2020 Jul; 583(7817):506-509. PubMed ID: 32681157
    [No Abstract]   [Full Text] [Related]  

  • 19. High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies.
    Boukli N; Le Mene M; Schnuriger A; Cuervo NS; Laroche C; Morand-Joubert L; Gozlan J
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32848041
    [No Abstract]   [Full Text] [Related]  

  • 20. [Not Available].
    Nau JY
    Rev Med Suisse; 2020 Jun; 16(696):1174-1175. PubMed ID: 32496708
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 35.